The JCR: LAcp Rat: Animal model of the metabolic syndrome exhibiting micro- and macrovascular disease

Animal Models of Diabetes, Second Edition: Frontiers in Research

Volumn , Issue , 2007, Pages 159-183

  Russell, James C ^a   Kelly, Sandra E ^a   Proctor, Spencer D ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 34248579337     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (74)

1. Absher PM, Schneider DJ, Baldor LC, et al. (1999) The retardation of vasculopathy induced by attenuation of insulin resistance in the corpulent JCR:LA-cp rat is reflected by decreased vascular smooth muscle cell proliferation in vivo. Atherosclerosis 143:245-251.
2. Absher PM, Schneider DJ, Russell JC, Sobel BE. (1997) Increased proliferation of explanted vascular smooth muscle cells: A marker presaging atherogenesis. Atherosclerosis 131:87-194.
3. Amy RM, Dolphin PJ, Pederson RA, Russel, JC. (1988) Atherogenesis in two strains of obese rats: The fatty Zucker and LA/N-corpulent. Atherosclerosis 69:199-209.
4. Anand SS, Yusuf S, Vuksan V, et al. (2002) Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: The Study of Health Assessment and Risk in Ethnic Groups (SHARE). Lancet 356:279-284.
5. Bauer BS, Ghahary A, Scott PG, et al. (2004) The JCR:LA:cp rat: A novel model for impaired wound healing. Wound Repair Regen 12:86-92.
6. Brindley DN, Russell JC. (2002) Animal models of insulin resistance and cardiovascular disease: Some therapeutic approaches using the JCR:LA-cp rat. Diabetes Obesity Metab 4:1-10.
7. Brunner F, Wölkart G, Russell JC, Wascher T. (2000) Vascular dysfunction and myocardial contractility in the JCR:LA-corpulent rat. Cardiovasc Res 47:150-158.
8. Chua SC Jr, White DW, Wu-Peng XS, et al. (1996) Phenotype of fatty due to Gln269Pro mutation in the leptin receptor (Lepr). Diabetes 45:1141-1143.
9. Cussons AJ, Stuckey BGA, Watts GF. (2006) Cardiovascular disease in the polycystic ovary syndrome: New insights and perspectives. Atherosclerosis 185:227-239.
10. Deng X, Elam MB, Wilcox HG, et al. (2004) Dietary olive oil and menhaden oil mitigate induction of lipogenesis in hyperinsulinemic corpulent JCR:LA-cp rats: Microarray analysis of lipid-related gene expression. Endocrinology 145:5847-5861.
11. Dolphin PJ, Amy RM, Koeslag DG, et al. (1988) Reduction of hyperlipidemia in the LA/Ncorpulent rat by dietary fish oil containing omega-3 fatty acids. Biochim Biophys Acta 962:317-329.
12. Dolphin PJ, Stewart B, Amy RM, Russell JC. (1987) Serum lipids and lipoproteins in the atherosclerosis prone LA/N-corpulent rat. Biochim Biophys Acta 919:140-148.
13. Elam MB, Wilcox HG, Cagen LM, et al. (2001) Increased hepatic VLDL secretion, lipogenesis, and SREBP-1 expression in the corpulent JCR:LA-cp rat. J Lipid Res 42:2039-2048.
14. Emilsson V, Lim YL, Cawthorne MA, et al. (1997) Expression of the functional leptin receptor in RNA in pancreatic islets and directly inhibitory action of leptin on insulin secretion. Diabetes 46:313-316.
15. Greenhouse DD, Michaelis OE IV, Peterson RG. (1988) The development of fatty and corpulent rat strains. In New Models of Genetically Obese Rats for Studies in Diabetes, Heart Disease and Complications of Obesity, ed. Hansen CT, Michaelis OE IV, National Institutes of Health, Bethesda, MD, 3-6.
16. Gupta M, Doobay AV, Singh N, et al. (2002) Risk factors, hospital management and outcomes after acute myocardial infarction in South Asian Canadians and matched control subjects. CMAJ 166:717-722.
17. Haas GJ, McCune SA, Brown DM, Cody RJ. (1995) Echocardiographic characterization of left ventricular adaptation in a genetically determined heart failure rat model. Am Heart J 130:806-811.
18. Hansen CT. (1983) Two new congenic rat strains for nutrition and obesity research. Fed Proc 42:537.
19. Hegele RA, Zinman B, Hanley AJG, et al. (2003) Genes, environment and Oji-Cree type 2 diabetes. Clin Biochem 36:63-170.
20. Koletsky S. (1973) Obese spontaneously hypertensive rats: A model for the study of atherosclerosis. Exp Mol Pathol 19:52-60.
21. Koletsky S. (1975) Pathological findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80:29-142.
22. Leza JC, Salas E, Sawicki G, et al. (1998) The effect of stress on homeostasis in JCR:LAcp rats. Role of nitric oxide. J Pharmacol Exp Ther 28:1397-1403.
23. Lopaschuk GD, Russell JC. (1991) Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA-corpulent rat. J Appl Physiol 71:1302-1308.
24. Lucas DL, Brown RA, Wassef M, et al. (2005) Alcohol and the cardiovascular system research challenges and opportunities. J Am Coll Cardiol 45:1916-1924.
25. Mamo JC, Watts GF, Barrett PH, et al. (2001) Postprandial dyslipidemia in men with visceral obesity: An effect of reduced LDL receptor expression? Am J Physiol 281:E626-E632.
26. McArthur MD, Graham SE, Russell JC, Brindley DN. (1998) Exaggerated stress-induced release of nonesterified fatty acids in JCR:LA-corpulent rats. Metabolism 47:1383-1390.
27. McClelland GB, Kraft CS, Michaud D, et al. (2004) Leptin and the control of respiratory gene expression in muscle. Biochim Biophys Acta 1688:86-93.
28. McCune S, Park S, Radin MJ, Jurin RR. (1995) The SHHF/Mcc-facp: A genetic model of congestive heart failure. In Mechanisms of Heart Failure, ed. Singal PK, Beamish RE, Dhalla NS. Kluwer Academic, Boston, 91-106.
29. Molitch ME, DeFronzo RA, Franz MJ, et al. (2004) Nephropathy in diabetes. Diabetes Care 27:(Suppl 1), S79-S83.
30. Morse AD, Hunt TWM, Wood GO, Russell JC. (1995) Diurnal variation of intensive running in food-deprived rats. Can J Physiol Pharmacol 73:1519-1523.
31. O’Brien SF, McKendrick JD, Radomski MW, et al. (1998) Vascular wall reactivity in conductance and resistance arteries: Differential effects of insulin resistance. Can J Physiol Pharmacol 76:72-76.
32. O’Brien SF, Russell JC. (1997) Insulin resistance and vascular wall function: Lessons from animal models. Endocrin Metab 4:155-162.
33. O’Brien SF, Russell JC, Dolphin PJ, Davidge ST. (2000) Vascular wall function in insulinresistant JCR:LA-cp rats: Role of male and female sex. J Cardiov Pharmacol 36:176-181.
34. O’Neill MS, Veves A, Zanobetti A, et al. (2005) Diabetes enhances vulnerability to particulate air pollution-associated impairment in vascular reactivity and endothelial function. Circulation 111:2913-2920.
35. Pederson RA, Campos RV, Buchan AMJ, et al. (1991) Comparison of the enteroinsular axis in two strains of obese rats: The fatty Zucker and JCR:LA-corpulent. Int J Obes 15:461-470.
36. Poiley SM. (1960) A systematic method of breeder rotation for noninbred laboratory animal colonies. Anim Care Panel 10:59-161.
37. Proctor SD, Dreher KL, Kelly SE, Russell JC. (2006) Hypersensitivity of prediabetic JCR:LAcp rats to fine airborne combustion particle-induced direct and noradrenergic-mediated vascular contraction. Toxicol Sci 90:385-391.
38. Proctor SD, Kelly SE, Stanhope KL, et al. (2006) Synergistic effects of conjugated linoleic acid and chromium picolinate improve vascular function and renal pathophysiology in the insulin-resistant JCR:LA-cp rat. Diabetes Obesity Metab, in press.
39. Proctor SD, Vine DF, Mamo JCL. (2002) Arterial retention of apolipoprotein-B48 and B100- containing lipoproteins in atherogenesis. Curr Opin Lipidol 13:461-470.
40. Proctor SD, Vine D.F, Mamo JC. (2004) Arterial permeability and efflux of apolipoprotein B-containing lipoproteins assessed by in situ perfusion and three-dimensional quantitative confocal microscopy. Arterioscler Thromb Vasc Biol 24:2162-2167.
41. Recant L, Voyles NR, Timmers KI, et al. (1989) Comparison of insulin secretory patterns in obese nondiabetic LA/N-cp and obese diabetic SHR/N-cp rats. Role of hyperglycemia. Diabetes 38:691-697.
42. Ruben Z, Miller JE, Rohrbacher E, Walsh GM. (1984) A potential model for a human disease: spontaneous cardiomyopathy-congestive heart failure in SHR/N-cp rats. Hum Pathol 15:902-903.
43. Russell JC, Amy RM, Dolphin PJ. (1991) Effect of n-3 fatty acids on atherosclerosis prone JCR:LA-corpulent rats. Exp Mol Pathol 55:285-293.
44. Russell JC, Amy RM, Graham S, Dolphin PJ. (1993) Effect of castration on hyperlipidemic, insulin resistant JCR:LA-corpulent rats. Atherosclerosis100:113-122.
45. Russell JC, Amy RM, Graham SE, et al. (1995) Inhibition of atherosclerosis and myocardial lesions in the JCR:LA-cp rat by ß-ß‘tetramethylhexadecanedioic acid (MEDICA 16). Arterioscler Thromb Vasc Biol 15:918-923.
46. Russell JC, Amy RM, Manickavel V, Dolphin PJ. (1989) Effects of chronic ethanol consumption in atherosclerosis-prone JCR:LA-corpulent rat. Arteriosclerosis 9:122-128.
47. Russell JC, Amy RM, Manickavel V, et al. (1987) Insulin resistance and impaired glucose tolerance in the atherosclerosis prone LA/N-corpulent rat. Arteriosclerosis 7:620-626.
48. Russell JC, Amy RM, Manickavel V, et al. (1989) Prevention of myocardial disease in the JCR:LA-corpulent rat by running. J Appl Physiol 66:1649-1655.
49. Russell JC, Amy RM, Michaelis OE IV, et al. (1991) Myocardial disease in corpulent strains of rats. In Lessons from Animal Diabetes, ed. Shafrir, E. Smith-Gordon, London, 3:402-407.
50. Russell JC, Bar-Tana J, Shillabeer G, et al. (1998) Development of insulin resistance in the JCR:LA-cp rat: Role of triacylglycerols and effects of MEDICA 16. Diabetes 47:770-778.
51. Russell JC, Dolphin PJ, Graham SE, et al. (1998) Improvement of insulin sensitivity and cardiovascular outcomes in the JCR:LA-cp rat by D-fenfluramine. Diabetologia 41:380-389.
52. Russell JC, Ewart HS, Kelly SE, et al. (2002) Improvement of vascular dysfunction in insulin resistance by a marine oil-based phytosterol compound. Lipids 37:147-152.
53. Russell JC, Graham SE, Amy RM, Dolphin PJ. (1998a) Cardioprotective effect of probucol in the atherosclerosis-prone JCR:LA-cp rat. Eur J Pharmacol 350:203-210.
54. Russell JC, Graham SE, Amy RM, Dolphin PJ. (1998b) Inhibition of myocardial lesions in the JCR:LA-corpulent rat by captopril. J Cardiovasc Pharmacol 31:971-977.
55. Russell JC, Graham SE, Dolphin PJ, et al. (1997) Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats. Atherosclerosis 132:187-197.
56. Russell JC, Graham SE, Dolphin PJ. (1999) Glucose tolerance and insulin resistance in the JCR:LA-cp rat: Effect of miglitol (Bay m1099). Metabolism 48:701-706.
57. Russell JC, Graham S, Hameed M. (1994) Abnormal insulin and glucose metabolism in the JCR:LA-corpulent rat. Metabolism 43:538-543.
58. Russell JC, Kelly SE, Schäfer S. (2004) Vasopeptidase inhibition improves insulin sensitivity and endothelial function in the JCR:LA-cp rat. J Cardiovasc Pharmacol 44:258-265.
59. Russell JC, Koeslag DG, Amy RM, Dolphin PJ. (1989) Plasma lipid secretion and clearance in the hyperlipidemic JCR:LA-corpulent rat. Arteriosclerosis 9:869-876.
60. Russell JC, Manickavel V, Koeslag DG, Amy RM. (1990) Effects of advancing age and severe food restriction on pathological processes in the insulin resistant JCR:LA-corpulent rat. Diabetes Res 15:53-62.
61. Russell JC, Ravel D, Pégorier J-P, et al. (2000) Beneficial insulin-sensitizing and vascular effects of S15261 in the insulin-resistant JCR:LA-cp rat. J Pharm Exp Ther 295:753-760.
62. Savage S, Estacio RO, Jeffers B, Schrier RW. (1996) Urinary albumin excretion as a predictor of diabetic retinopathy, neuropathy, and cardiovascular disease in NIDDM. Diabetes Care 19:1243-1248.
63. Schaefer EJ, McNamara JR, Shah PK, et al. (2002) Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care 25:989-994.
64. Schneider DJ, Absher PM, Neimane D, et al. (1998) Fibrinolysis and atherogenesis in the JCR:LA-cp rat in relation to insulin and triglyceride concentrations in blood. Diabetologia 41:141-147.
65. Steiner G. (1994) Hyperinsulinemia and hypertriglyceridemia. J Int Med 736(suppl):23-26.
66. Triana RJ, Suits GW, Garrison S, et al. (1991) Inner ear damage secondary to diabetes mellitus. I. Changes in adolescent SHR/N-cp rats. Arch Otolarynol 117:635-640.
67. Velasquez MT, Abraham AA, Kimmel PL, et al. (1995) Diabetic glomerulopathy in the SHR/N-corpulent rat: Role of dietary carbohydrate in a model of NIDDM. Diabetologia 38:31-38.
68. Vine DF, Russell JC, Proctor SD. (2005) Impaired metabolism of chylomicrons and corresponding postprandial response can contribute to accelerated vascular disease in the JCR:LA cp/cp rat model of obesity and insulin resistance. Can J Cardiol 21(Suppl. C):A677.
69. Wascher TC, Wölkart G, Russell JC, Brunner F. (2000) Delayed insulin transport across endothelium in insulin resistant JCR:LA-cp rats. Diabetes 49:803-809.
70. Williams G, Cardoso H, Domin J, et al. (1990) Disturbances of regulatory peptides in the hypothalamus of the JCR:LA-corpulent rat. Diabetes Res 15:1-7.
71. Williams G, Shellard L, Lewis DA, et al. (1992) Hypothalamic neuropeptide Y disturbances in the obese cp/cp JCR:LA-corpulent rat. Peptides 13:537-540.
72. Wu-Peng XS, Chua SC Jr., Okada N, et al. (1997) Phenotype of the obese Koletsky (f) rat due to Tyr763Stop mutation in the extracellular domain of the leptin receptor (Lepr). Diabetes 46:513-518.
73. Yamini S, Carswell N, Michaelis OE IV, Szepesi B. (1992) Adaptation in enzyme (metabolic) pathways to obesity, carbohydrate diet and to the occurence of NIDDM in male and female SHR/N-cp rats. Int J Obesity 16:765-774.
74. Zucker LM, Zucker TF. (1961) Fatty, a new mutation in the rat. J Heredity 52:275-278.